These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

612 related items for PubMed ID: 21376033

  • 1. A novel epoxypropoxy flavonoid derivative and topoisomerase II inhibitor, MHY336, induces apoptosis in prostate cancer cells.
    Patra N, De U, Kang JA, Kim JM, Ahn MY, Lee J, Jung JH, Chung HY, Moon HR, Kim HS.
    Eur J Pharmacol; 2011 May 11; 658(2-3):98-107. PubMed ID: 21376033
    [Abstract] [Full Text] [Related]

  • 2. WRC-213, an l-methionine-conjugated mitoxantrone derivative, displays anticancer activity with reduced cardiotoxicity and drug resistance: identification of topoisomerase II inhibition and apoptotic machinery in prostate cancers.
    Hsiao CJ, Li TK, Chan YL, Hsin LW, Liao CH, Lee CH, Lyu PC, Guh JH.
    Biochem Pharmacol; 2008 Feb 15; 75(4):847-56. PubMed ID: 18035333
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and evaluation of aroylthiourea derivatives of 4-β-amino-4'-O-demethyl-4-desoxypodophyllotoxin as novel topoisomerase II inhibitors.
    Zhao Y, Ge CW, Wu ZH, Wang CN, Fang JH, Zhu L.
    Eur J Med Chem; 2011 Mar 15; 46(3):901-6. PubMed ID: 21277655
    [Abstract] [Full Text] [Related]

  • 4. Adenosine induces cell-cycle arrest and apoptosis in androgen-dependent and -independent prostate cancer cell lines, LNcap-FGC-10, DU-145, and PC3.
    Aghaei M, Karami-Tehrani F, Panjehpour M, Salami S, Fallahian F.
    Prostate; 2012 Mar 15; 72(4):361-75. PubMed ID: 21656837
    [Abstract] [Full Text] [Related]

  • 5. A novel histone deacetylase (HDAC) inhibitor MHY219 induces apoptosis via up-regulation of androgen receptor expression in human prostate cancer cells.
    Patra N, De U, Kim TH, Lee YJ, Ahn MY, Kim ND, Yoon JH, Choi WS, Moon HR, Lee BM, Kim HS.
    Biomed Pharmacother; 2013 Jun 15; 67(5):407-15. PubMed ID: 23583193
    [Abstract] [Full Text] [Related]

  • 6. Growth of human prostate cancer cells is significantly suppressed in vitro with sodium butyrate through apoptosis.
    Qiu J, Gao Z, Shima H.
    Oncol Rep; 2012 Jan 15; 27(1):160-7. PubMed ID: 21947091
    [Abstract] [Full Text] [Related]

  • 7. N-fused imidazoles as novel anticancer agents that inhibit catalytic activity of topoisomerase IIα and induce apoptosis in G1/S phase.
    Baviskar AT, Madaan C, Preet R, Mohapatra P, Jain V, Agarwal A, Guchhait SK, Kundu CN, Banerjee UC, Bharatam PV.
    J Med Chem; 2011 Jul 28; 54(14):5013-30. PubMed ID: 21644529
    [Abstract] [Full Text] [Related]

  • 8. Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity.
    Kassab AE, Gedawy EM.
    Eur J Med Chem; 2018 Apr 25; 150():403-418. PubMed ID: 29547830
    [Abstract] [Full Text] [Related]

  • 9. Quercetin-3-O-glucoside induces human DNA topoisomerase II inhibition, cell cycle arrest and apoptosis in hepatocellular carcinoma cells.
    Sudan S, Rupasinghe HP.
    Anticancer Res; 2014 Apr 25; 34(4):1691-9. PubMed ID: 24692698
    [Abstract] [Full Text] [Related]

  • 10. One-pot synthesis of podophyllotoxin-thiourea congeners by employing NH₂SO₃H/NaI: Anticancer activity, DNA topoisomerase-II inhibition, and apoptosis inducing agents.
    Shankaraiah N, Kumar NP, Amula SB, Nekkanti S, Jeengar MK, Naidu VG, Reddy TS, Kamal A.
    Bioorg Med Chem Lett; 2015 Oct 01; 25(19):4239-44. PubMed ID: 26292628
    [Abstract] [Full Text] [Related]

  • 11. Berberine inhibits p53-dependent cell growth through induction of apoptosis of prostate cancer cells.
    Choi MS, Oh JH, Kim SM, Jung HY, Yoo HS, Lee YM, Moon DC, Han SB, Hong JT.
    Int J Oncol; 2009 May 01; 34(5):1221-30. PubMed ID: 19360335
    [Abstract] [Full Text] [Related]

  • 12. The novel antimicrotubule agent cryptophycin 52 (LY355703) induces apoptosis via multiple pathways in human prostate cancer cells.
    Drew L, Fine RL, Do TN, Douglas GP, Petrylak DP.
    Clin Cancer Res; 2002 Dec 01; 8(12):3922-32. PubMed ID: 12473608
    [Abstract] [Full Text] [Related]

  • 13. Extended survivability of prostate cancer cells in the absence of trophic factors: increased proliferation, evasion of apoptosis, and the role of apoptosis proteins.
    Tang DG, Li L, Chopra DP, Porter AT.
    Cancer Res; 1998 Aug 01; 58(15):3466-79. PubMed ID: 9699682
    [Abstract] [Full Text] [Related]

  • 14. Nitroxide tempo, a small molecule, induces apoptosis in prostate carcinoma cells and suppresses tumor growth in athymic mice.
    Suy S, Mitchell JB, Samuni A, Mueller S, Kasid U.
    Cancer; 2005 Mar 15; 103(6):1302-13. PubMed ID: 15685617
    [Abstract] [Full Text] [Related]

  • 15. Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts.
    Chiu FL, Lin JK.
    Prostate; 2008 Jan 01; 68(1):61-71. PubMed ID: 18008333
    [Abstract] [Full Text] [Related]

  • 16. Suppression of human prostate cancer cell growth by ciprofloxacin is associated with cell cycle arrest and apoptosis.
    Aranha O, Grignon R, Fernandes N, McDonnell TJ, Wood DP, Sarkar FH.
    Int J Oncol; 2003 Apr 01; 22(4):787-94. PubMed ID: 12632069
    [Abstract] [Full Text] [Related]

  • 17. Regulation by survivin of cancer cell death induced by F14512, a polyamine-containing inhibitor of DNA topoisomerase II.
    Ballot C, Jendoubi M, Kluza J, Jonneaux A, Laine W, Formstecher P, Bailly C, Marchetti P.
    Apoptosis; 2012 Apr 01; 17(4):364-76. PubMed ID: 22127645
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and topoisomerase II inhibitory and cytotoxic activity of oxiranylmethoxy- and thiiranylmethoxy-chalcone derivatives.
    Na Y, Nam JM.
    Bioorg Med Chem Lett; 2011 Jan 01; 21(1):211-4. PubMed ID: 21115246
    [Abstract] [Full Text] [Related]

  • 19. Differential involvement of reactive oxygen species and nucleoside transporters in cytotoxicity induced by two adenosine analogues in human prostate cancer cells.
    Minelli A, Bellezza I, Tucci A, Rambotti MG, Conte C, Culig Z.
    Prostate; 2009 Apr 01; 69(5):538-47. PubMed ID: 19107848
    [Abstract] [Full Text] [Related]

  • 20. A novel anticancer agent, decursin, induces G1 arrest and apoptosis in human prostate carcinoma cells.
    Yim D, Singh RP, Agarwal C, Lee S, Chi H, Agarwal R.
    Cancer Res; 2005 Feb 01; 65(3):1035-44. PubMed ID: 15705905
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.